Private Capital Advisors Inc. Sells 2,992 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Private Capital Advisors Inc. trimmed its position in Bath & Body Works, Inc. (NYSE:BBWIGet Rating) by 1.7% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 177,852 shares of the company’s stock after selling 2,992 shares during the period. Bath & Body Works makes up approximately 2.0% of Private Capital Advisors Inc.’s holdings, making the stock its 17th biggest holding. Private Capital Advisors Inc.’s holdings in Bath & Body Works were worth $12,412,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Acadian Asset Management LLC bought a new position in Bath & Body Works during the fourth quarter worth $30,000. CX Institutional bought a new position in shares of Bath & Body Works in the 3rd quarter worth $34,000. CWM LLC bought a new position in Bath & Body Works during the 4th quarter valued at $42,000. Signaturefd LLC raised its stake in shares of Bath & Body Works by 72.4% during the 4th quarter. Signaturefd LLC now owns 693 shares of the company’s stock worth $48,000 after purchasing an additional 291 shares during the period. Finally, Rockefeller Capital Management L.P. purchased a new stake in Bath & Body Works in the 3rd quarter worth about $57,000. Institutional investors own 97.11% of the company’s stock.

Several analysts have weighed in on the company. Telsey Advisory Group lowered their price objective on Bath & Body Works from $91.00 to $70.00 and set an “outperform” rating for the company in a research report on Thursday, February 24th. Wells Fargo & Company reduced their price target on Bath & Body Works from $85.00 to $70.00 and set an “overweight” rating on the stock in a research note on Tuesday, April 5th. Cowen raised Bath & Body Works from a “market perform” rating to an “outperform” rating in a research note on Monday, May 2nd. Zacks Investment Research cut Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Monday. Finally, B. Riley cut their target price on Bath & Body Works from $91.00 to $76.00 and set a “buy” rating on the stock in a research note on Friday, February 25th. Three equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Buy” and an average target price of $78.63.

Shares of NYSE BBWI traded up $0.77 during trading on Thursday, hitting $48.54. The company had a trading volume of 6,274,889 shares, compared to its average volume of 4,499,470. The stock has a 50 day simple moving average of $50.26 and a 200 day simple moving average of $60.00. Bath & Body Works, Inc. has a 12 month low of $44.17 and a 12 month high of $82.00. The firm has a market capitalization of $11.58 billion, a P/E ratio of 10.03, a price-to-earnings-growth ratio of 1.23 and a beta of 1.56.

Bath & Body Works (NYSE:BBWIGet Rating) last posted its quarterly earnings data on Wednesday, February 23rd. The company reported $2.30 EPS for the quarter, topping the consensus estimate of $2.27 by $0.03. Bath & Body Works had a negative return on equity of 115.32% and a net margin of 14.13%. The firm had revenue of $3.03 billion for the quarter, compared to the consensus estimate of $2.96 billion. During the same quarter last year, the company earned $1.96 earnings per share. The business’s revenue for the quarter was up 11.4% compared to the same quarter last year. Equities analysts anticipate that Bath & Body Works, Inc. will post 4.62 EPS for the current fiscal year.

In related news, CFO Wendy C. Arlin sold 6,000 shares of the stock in a transaction dated Tuesday, April 19th. The stock was sold at an average price of $55.00, for a total transaction of $330,000.00. Following the completion of the sale, the chief financial officer now owns 98,888 shares in the company, valued at $5,438,840. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.37% of the company’s stock.

Bath & Body Works Company Profile (Get Rating)

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. The company sells its products under the Bath & Body Works, White Barn, and other brand names through specialty retail stores and websites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.

Featured Articles

Want to see what other hedge funds are holding BBWI? Visit to get the latest 13F filings and insider trades for Bath & Body Works, Inc. (NYSE:BBWIGet Rating).

Institutional Ownership by Quarter for Bath & Body Works (NYSE:BBWI)

Receive News & Ratings for Bath & Body Works Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bath & Body Works and related companies with's FREE daily email newsletter.